Year-End Push To Meet FDAAA Puts 14 Advisory Committee Meetings On Tap
This article was originally published in The Tan Sheet
Executive Summary
The Center for Drug Evaluation and Research will hold more than twice the typical number of advisory committee meetings in November and December this year - capping off a significant overall increase in panels convened in 2008
You may also be interested in...
Traditional Chinese Medicine Grows As Target For New Drug Opportunities
Nestle Health and Hutchison China MediTech’s JV has an ongoing phase III trial hoping to validate traditional Chinese medicine for Western health care systems. Reports of TCM contamination at China-based firms represent a market-incursion opportunity for Western firms with established supply chains.
Traditional Chinese Medicine Grows As Target For New Drug Opportunities
Nestle Health and Hutchison China MediTech’s JV has an ongoing phase III trial hoping to validate traditional Chinese medicine for Western health care systems. Reports of TCM contamination at China-based firms represent a market-incursion opportunity for Western firms with established supply chains.
FDA Using More Temporary Advisory Committee Members To Fill Vacancies
FDA advisory committees are increasingly relying on temporary members to fill their ranks - a trend that could result in less predictability for drug sponsors at a make-or-break review meeting